Radial Head FracturesNCT05415592
A Study of Participants Undergoing Radial Head Replacement Using the DePuy Synthes Radial Head Replacement System for Partial Replacement of the Elbow Joint
An observational study of Radial Head Fractures, run by DePuy Synthes Products, Inc. at 4 sites in 2 countries.
Trial summary
The purpose of this study is to establish survivorship defined by the cumulative incidence of revision over the first 6 months post-implantation. Read more about this study
- Who is it for?
- Ages 22 years and older
- Conditions the study is for
- Radial Head Fractures
- What is being tested?
- DePuy Synthes Radial Head Replacement System
- Type of treatment
- Medical device
- How many people
- 0 participants
- Where
- 4 sitesin 2 countries
- Study dates
- 31 Mar 2023to 31 Mar 2030
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study will include skeletally mature adult participants aged 22 or older who are scheduled to undergo radial head replacement.
Who may be able to join
- Male or female - skeletally mature adult (aged 22 or older)
- Participant, who in the opinion of the Investigator, is able to understand the purpose of the study and is willing to return for all the required post-operative standard of care follow-up visits and have their data collected
- Participant who is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
- Any one of below:
- Primary replacement after fracture of the radial head
- Participant needing a partial radial head replacement for degenerative or post-traumatic conditions presenting pain, crepitation, and decreased motion at the radio-humeral and/or proximal radio-ulnar joint with: i) joint destruction and/or subluxation visible on x-ray and/or ii. resistance to conservative treatment
- Symptomatic sequelae after radial head resection
- Revision following failed radial head arthroplasty
Who cannot join
- Dislocations of radius on ulna that would not allow a radio-humeral articulation
- Rheumatoid arthritis
- Infection, sepsis, and osteomyelitis
- Uncooperative participant or participant with neurologic disorders who is incapable of following directions, osteoporosis, metabolic disorders which may impair bone formation, osteomalacia, distant foci of infections which may spread to the implant site, rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- Participants with limited life expectancy due to significant medical co-morbidity
- Presence of major vascular or major nerve injury (radial, ulnar, medial, musculocutaneous)
Show all 12Show fewer
- Women who are pregnant or lactating
- Unable to comply with study requirements example, with maintaining follow-up
- Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims
- Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months
- Demented or unable to provide informed consent
- Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have psychological disorders that could affect their ability to complete participant reported questionnaires or be compliant with follow-up requirements
Trial locations and contacts
4 sites in 2 countries.
4 sites in 2 countries
United States3 sites
MetroHealth Medical Center
Cleveland, Ohio, 44109
Slocum Research & Education Foundation
Eugene, Oregon, 97401
Inova Orthopaedics - Fairfax
Falls Church, Virginia, 22042
United Kingdom1 site
Glasgow Royal Infirmary (NHS Greater Glasgow & Clyde)
Glasgow, G40SF
About this study
Official title: A Multi-Center, Post-Market, Single-Arm, Observational Clinical Follow-Up Study of Patients Undergoing Radial Head Replacement Using the DePuy Synthes Radial Head Replacement System for Partial Replacement of the Elbow Joint
The purpose of this study is to establish survivorship defined by the cumulative incidence of revision over the first 6 months post-implantation.
- Conditions
- Radial Head Fractures
- Being tested
- DePuy Synthes Radial Head Replacement System
- Keywords
- Radial Head Replacement, Radial Head Prosthesis, DePuy Synthes,, Partial Elbow Replacement, Device Survivorship
- Medical subject headings
- Radial Head and Neck Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DePuy Synthes Radial Head Replacement SystemDevice
DePuy Synthes Radial Head Replacement System will be used for radial head replacement or partial replacement of the elbow joint.
| Study group | Role | What they receive |
|---|---|---|
| DePuy Synthes Radial Head Replacement System | Participants will undergo a radial head replacement or partial replacement of the elbow joint with the DePuy Synthes Radial Head Replacement System. Receives: Device: DePuy Synthes Radial Head Replacement System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Device survivorship Over the First 6 Months Post-implantation
Device survivorship is defined by the cumulative incidence of absence of revision. A revision is considered to be any procedure that involves removal of the implant (that is, removal of the Radial Head Prosthesis [RHP], replacement with another RHP or revision surgery to a total elbow arthroplasty).
Measured: 6 months post-implantation
Secondary outcomes (20)
Number of Participant with Revision Radial Head Replacement (RHR) Surgery
Number of participants with revision RHR surgery will be reported. Revision surgery reasons include symptomatic aseptic loosening, elbow stiffness, persistent pain, infection, elbow instability, overlengthening, dissociation of the prosthesis, progressive symptomatic ulnohumeral degeneration, secondary fracture, heterotopic ossification, osteoarthritis, erosions of the capitellum, or other implant-related complications.
Measured: Up to 4 years post surgery
Assessment of Radiographic Parameters: Mason Classification of Radial Head Fractures
Mason classification system will be used for the classification of radial head fractures. It includes four radial head fracture types. Mason Type I are non-displaced radial head fractures (or small marginal fractures), Mason Type II are partial articular fractures with displacement, Mason Type III are comminuted fractures involving the entire radial head, and Mason Type IV are fractures of the radial head with dislocation of the elbow joint.
Measured: Preoperative, Operative, Discharge (up to Day 6)
Assessment of Radiographic Parameters: Radiolucency
Radiolucency will be assessed based on the number of zones involved and the amount of lucency (in millimeters) observed. Radiolucency is classified as: a) None; b) Mild: one or two zones involved by lucent lines of less than (<) 2 millimeters (mm) in thickness; c) Moderate: three to six zones involved or the lucency of greater than or equal to (>=) 2 mm in thickness and d) Severe: all seven zones involved.
Measured: At Months 6, 12, and 24
Assessment of Radiographic Parameters: Radiocapitellar Alignment
Radiocapitellar alignment will be determined. The position of the radial head prosthesis is assessed on a lateral X-ray based on the intersection between the axis of the prosthetic shaft and the center of the capitellum. The calculation is based on the quotient of the diameter of the trochlea humeri and the axis of the prosthesis.
Measured: Operative at Week 2, and 6, Months 3, 6, 12, 24, and 48 post operative
Assessment of Radiographic Parameters: Ulnohumeral Degeneration
Ulnohumeral degeneration will be assessed. The degree of ulnohumeral degeneration is classified with the system described by Broberg and Morrey as Grade 0 (normal joint), Grade 1 (slight joint space narrowing with minimum osteophyte formation), Grade 2 (moderate joint space narrowing with moderate osteophyte formation) or Grade 3 (severe degenerative changes with gross destruction of the joint).
Measured: Operative at Week 2, and 6, Months 3, 6, 12, 24, and 48 post operative
Assessment of Radiographic Parameters: Osteoarthritis
Osteoarthritis (in the radio-capitellar joint) will be assessed. Osteoarthritis is evaluated as yes/no, if yes, the location will be described (that is., medial, lateral or both).
Measured: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Heterotopic Ossification
Heterotopic ossification will be determined and reported. Heterotopic ossification is classified as present (that is, anterior-posterior, medial-lateral) or absent.
Measured: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Osteopenia, and/or Capitellar Abrasion
Osteopenia, and/or capitellar abrasion will be determined and reported. Capitellar osteopenia and/or abrasion is classified as none, mild, moderate, or severe.
Measured: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Overlengthening
Overlengthening will be determined and reported. Overlengthening is assessed on the intra- or postoperative, 6-, 12- and 24 months Antero-Posterior (AP) and lateral X-rays (evidence of overstuffing).
Measured: Operative at Months 6, 12, and 24 post operative
Assessment of Radiographic Parameters: Joint incongruity
Joint incongruity will be determined and reported. Joint incongruity is assessed as yes/no.
Measured: Operative at Week 2, and 6, Months 3, 6, 12, 24 and 48 post operative
Mayo Elbow Performance Index (MEPI) Score
MEPI is also known as Mayo Elbow Performance Score (MEPS). MEPI is used to evaluate the clinical outcomes for a variety of elbow disorders such as elbow fractures and dislocations. The MEPI is a validated hundred-point system based upon pain (forty five points), range of motion (twenty points), stability (ten points) and daily function (twenty five points) The scale ranges from 0 to 100, with a higher score indicating a better outcome.
Measured: Week 2 and 6, Months 3, 6, 12, 24, and 48
Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) Score
QuickDASH questionnaire has 30-items, which includes 21 items for physical function, 6 for symptoms, and 3 for social roles. Quick DASH is a shorter version, developed for less burden to the responder. It consists of 11 items out of the original 30 questions of the DASH. QuickDASH is scored between 0 (no disability) to 100 (most severe disability), with lower scores indicating better overall wellness.
Measured: Week 2 and 6, Months 3, 6, 12, 24, and 48
Elbow Range of Motion (ROM)
Elbow ROM of both sites (injured side and contralateral side) will be assessed according to standard of care practices for elbow flexion, elbow extension, forearm supination, and forearm pronation.
Measured: Week 2 and 6, Months 3, 6, 12, 24, and 48
Grip Strength of the Injured Limb Compared to the Contralateral Side
The grip strength (if available) will be assessed with dynamometer following the standardized testing protocol recommended by the American Society of Hand Therapists (ASHT). For measurements, the participants would be in a comfortable sitting position in a chair without arm rests, with feet fully resting on the floor, hips as far back in the chair as possible, and the hips and knees positioned at approximately 90 degrees. Grip force should be applied smoothly, without rapid wrenching or jerking motion. (No correction for hand dominance will be performed because this effect varies substantially among users. Assessment will be also performed on the unaffected side using the same method.
Measured: At Week 6, Months 6, 12, 24 and 48
European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L) Scale Score
EQ-5D-5L questionnaire includes five questions (descriptive system: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a visual analog scale to rate the current health status. The resulting scores were converted into a single index score that ranged from -0.281 to 1, where higher score indicates better health. Values lower than 0 represent states considered to be worse than death.
Measured: Preoperative, Week 6, Months 6, 12, 24, and 48
Local Pain Assessed by Numerical Rating Scale (NRS) Score
Local pain intensity levels over the previous 24 hours will be assessed with the Numerical Rating Scale (NRS). The scale range goes from 0 (no pain) to 10 (worst imaginable pain). A higher value correlates with greater pain.
Measured: Week 2 and 6, Months 3, 6, 12, 24, and 48
Number of Participants who Return to Work and Sport
Number of participants who return to work and Sport will be assessed as yes/no.
Measured: Week 2 and 6, Months 3, 6, 12, 24, 36 and 48
Number of Participants with Device and/or Procedure-related Adverse Events (AEs)
Any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in participants, users or other persons, whether or not related to investigational medical device, the Radial Head Replacement System, and whether anticipated or unanticipated.
Measured: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Number of Participants with Device and/or Procedure-related Serious Adverse Events (SAEs)
SAEs are defined as any device and or procedure related adverse event that: 1. Led to death; 2. Serious deterioration in the health of the subject, that resulted in any of the following: a. life-threatening illness or injury, b. permanent impairment of a body structure or a body function, c. hospitalization or prolongation of existing hospitalization, d. medical or surgical intervention to prevent life-threatening illness or injury or permanent impairment to a body structure or a body function, e. chronic disease; 3. Led to fetal distress, fetal death or a congenital physical or mental impairment or birth defect.
Measured: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Number of Participants with Revision/Reoperations
Number of participants with revision/reoperation will be reported. A revision is considered to be any procedure that involves removal of the implant (that is, removal of the RHP, replacement with another RHP or revision surgery to a total elbow arthroplasty). Reoperation is defined as a second operation involving the DePuy Synthes Radial Head Replacement System at the index site and after the index surgery that does not include removal or replacement of the implanted Radial Head Prosthesis.
Measured: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jun 2022
- Study start31 Mar 2023 (estimated)
- Primary completion31 Mar 2026 (estimated)
- Study completion31 Mar 2030 (estimated)
Why it stopped: This was a business decision made due to competing regulatory commitments. Please note that this was not related to the safety or performance of the device.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (31)Papers the sponsor has linked to this study.
- Other trials for Radial Head FracturesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- DePuy Synthes Products, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- DePuy Synthes Products, Inc. Clinical Trial, Study director, DePuy Synthes Products, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05415592
- Sponsor's protocol ID
- DST202002
- Other IDs
- DST202002
- Status last verified
- Feb 2023
- First submitted
- 9 Jun 2022
- Last updated
- 16 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Agyeman KD, Damodar D, Watkins I, Dodds SD. Does radial head implant fixation affect functional outcomes? A systematic review and meta-analysis. J Shoulder Elbow Surg. 2019 Jan;28(1):126-130. doi: 10.1016/j.jse.2018.07.032. Epub 2018 Oct 17.
PubMed 30342823Bahreini M, Safaie A, Mirfazaelian H, Jalili M. How much change in pain score does really matter to patients? Am J Emerg Med. 2020 Aug;38(8):1641-1646. doi: 10.1016/j.ajem.2019.158489. Epub 2019 Nov 4.
PubMed 31744654Bain, G., Eygendaal, D., and van Riet, R. (2020). Surgical Techniques for Trauma and Sports Related Injuries of the Elbow
Broberg MA, Morrey BF. Results of delayed excision of the radial head after fracture. J Bone Joint Surg Am. 1986 Jun;68(5):669-74.
PubMed 3722222Churchill RW, Munoz J, Ahmad CS. Osteochondritis dissecans of the elbow. Curr Rev Musculoskelet Med. 2016 Jun;9(2):232-9. doi: 10.1007/s12178-016-9342-y.
PubMed 27125506Court-Brown CM, Caesar B. Epidemiology of adult fractures: A review. Injury. 2006 Aug;37(8):691-7. doi: 10.1016/j.injury.2006.04.130. Epub 2006 Jun 30.
PubMed 16814787Cusick MC, Bonnaig NS, Azar FM, Mauck BM, Smith RA, Throckmorton TW. Accuracy and reliability of the Mayo Elbow Performance Score. J Hand Surg Am. 2014 Jun;39(6):1146-50. doi: 10.1016/j.jhsa.2014.01.041. Epub 2014 Mar 20.
PubMed 24656392Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018 Jan;27(1):7-22. doi: 10.1002/hec.3564. Epub 2017 Aug 22.
PubMed 28833869Duckworth AD, McQueen MM, Ring D. Fractures of the radial head. Bone Joint J. 2013 Feb;95-B(2):151-9. doi: 10.1302/0301-620X.95B2.29877.
PubMed 23365021Fowler JR, Goitz RJ. Radial head fractures: indications and outcomes for radial head arthroplasty. Orthop Clin North Am. 2013 Jul;44(3):425-31, x. doi: 10.1016/j.ocl.2013.03.013. Epub 2013 Apr 17.
PubMed 23827844Gao Y, Zhang W, Duan X, Yang J, Al-Qwbani M, Lv J, Xiang Z. Surgical interventions for treating radial head fractures in adults. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008987. doi: 10.1002/14651858.CD008987.pub2.
PubMed 23728684Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011 Oct;107(4):619-26. doi: 10.1093/bja/aer195. Epub 2011 Jun 30.
PubMed 21724620Giannicola G, Sacchetti FM, Antonietti G, Piccioli A, Postacchini R, Cinotti G. Radial head, radiocapitellar and total elbow arthroplasties: a review of recent literature. Injury. 2014 Feb;45(2):428-36. doi: 10.1016/j.injury.2013.09.019. Epub 2013 Sep 19.
PubMed 24112701GmbH, S. (2020). Instructions for Use - Radial Head Replacement System (https://ifu.depuysynthes.com/?lang=en&archive=&keyword=Radial+Head).
Grewal R, MacDermid JC, Faber KJ, Drosdowech DS, King GJ. Comminuted radial head fractures treated with a modular metallic radial head arthroplasty. Study of outcomes. J Bone Joint Surg Am. 2006 Oct;88(10):2192-200. doi: 10.2106/JBJS.E.00962.
PubMed 17015596
Study at a glance
From the registry record, last updated by the sponsor on 16 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multi-Center, Post-Market, Single-Arm, Observational Clinical Follow-Up Study of Patients Undergoing Radial Head Replacement Using the DePuy Synthes Radial Head Replacement System for Partial Replacement of the Elbow Joint
- ClinicalTrials.gov ID
- NCT05415592
- Acronym / sponsor ID
- DST202002
- Conditions
- Radial Head Fractures
- Keywords
- Radial Head Replacement, Radial Head Prosthesis, DePuy Synthes,, Partial Elbow Replacement, Device Survivorship
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: This was a business decision made due to competing regulatory commitments. Please note that this was not related to the safety or performance of the device.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- DePuy Synthes Products, Inc.Industry (pharma, biotech, devices)
- Study start
- 31 Mar 2023 (estimated)
- Primary completion
- 31 Mar 2026 (estimated)
- Study completion
- 31 Mar 2030 (estimated)
- First posted
- 13 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to establish survivorship defined by the cumulative incidence of revision over the first 6 months post-implantation.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| DePuy Synthes Radial Head Replacement System | – | Device: DePuy Synthes Radial Head Replacement SystemParticipants will undergo a radial head replacement or partial replacement of the elbow joint with the DePuy Synthes Radial Head Replacement System. |
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study will include skeletally mature adult participants aged 22 or older who are scheduled to undergo radial head replacement.
Key inclusion criteria (8 listed)
- Male or female - skeletally mature adult (aged 22 or older)
- Participant, who in the opinion of the Investigator, is able to understand the purpose of the study and is willing to return for all the required post-operative standard of care follow-up visits and have their data collected
- Participant who is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
- Primary replacement after fracture of the radial head
- Participant needing a partial radial head replacement for degenerative or post-traumatic conditions presenting pain, crepitation, and decreased motion at the radio-humeral and/or proximal radio-ulnar joint with: i) joint destruction and/or subluxation visible on x-ray and/or ii. resistance to conservative treatment
Key exclusion criteria (12 listed)
- Dislocations of radius on ulna that would not allow a radio-humeral articulation
- Rheumatoid arthritis
- Infection, sepsis, and osteomyelitis
- Uncooperative participant or participant with neurologic disorders who is incapable of following directions, osteoporosis, metabolic disorders which may impair bone formation, osteomalacia, distant foci of infections which may spread to the implant site, rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- Participants with limited life expectancy due to significant medical co-morbidity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DePuy Synthes Radial Head Replacement SystemDePuy Synthes Radial Head Replacement System will be used for radial head replacement or partial replacement of the elbow joint. | Device | DePuy Synthes Radial Head Replacement System |
Primary outcome
Device survivorship Over the First 6 Months Post-implantation
Time frame: 6 months post-implantation
Device survivorship is defined by the cumulative incidence of absence of revision. A revision is considered to be any procedure that involves removal of the implant (that is, removal of the Radial Head Prosthesis [RHP], replacement with another RHP or revision surgery to a total elbow arthroplasty).
20 secondary outcomes
Number of Participant with Revision Radial Head Replacement (RHR) Surgery
Time frame: Up to 4 years post surgery
Assessment of Radiographic Parameters: Mason Classification of Radial Head Fractures
Time frame: Preoperative, Operative, Discharge (up to Day 6)
Assessment of Radiographic Parameters: Radiolucency
Time frame: At Months 6, 12, and 24
Assessment of Radiographic Parameters: Radiocapitellar Alignment
Time frame: Operative at Week 2, and 6, Months 3, 6, 12, 24, and 48 post operative
Assessment of Radiographic Parameters: Ulnohumeral Degeneration
Time frame: Operative at Week 2, and 6, Months 3, 6, 12, 24, and 48 post operative
Assessment of Radiographic Parameters: Osteoarthritis
Time frame: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Heterotopic Ossification
Time frame: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Osteopenia, and/or Capitellar Abrasion
Time frame: At Week 2, and 6, Months 3, 6, 12, 24, and 48
Assessment of Radiographic Parameters: Overlengthening
Time frame: Operative at Months 6, 12, and 24 post operative
Assessment of Radiographic Parameters: Joint incongruity
Time frame: Operative at Week 2, and 6, Months 3, 6, 12, 24 and 48 post operative
Mayo Elbow Performance Index (MEPI) Score
Time frame: Week 2 and 6, Months 3, 6, 12, 24, and 48
Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) Score
Time frame: Week 2 and 6, Months 3, 6, 12, 24, and 48
Elbow Range of Motion (ROM)
Time frame: Week 2 and 6, Months 3, 6, 12, 24, and 48
Grip Strength of the Injured Limb Compared to the Contralateral Side
Time frame: At Week 6, Months 6, 12, 24 and 48
European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L) Scale Score
Time frame: Preoperative, Week 6, Months 6, 12, 24, and 48
Local Pain Assessed by Numerical Rating Scale (NRS) Score
Time frame: Week 2 and 6, Months 3, 6, 12, 24, and 48
Number of Participants who Return to Work and Sport
Time frame: Week 2 and 6, Months 3, 6, 12, 24, 36 and 48
Number of Participants with Device and/or Procedure-related Adverse Events (AEs)
Time frame: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Number of Participants with Device and/or Procedure-related Serious Adverse Events (SAEs)
Time frame: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Number of Participants with Revision/Reoperations
Time frame: Operative, Discharge (up to Day 6), Week 2, 6, Months 3, 6, 12, 24, 36, and 48
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Feb 2023.
- Background: PubMed 30342823Agyeman KD, Damodar D, Watkins I, Dodds SD. Does radial head implant fixation affect functional outcomes? A systematic review and meta-analysis. J Shoulder Elbow Surg. 2019 Jan;28(1):126-130. doi: 10.1016/j.jse.2018.07.032. Epub 2018 Oct 17.
- Background: PubMed 31744654Bahreini M, Safaie A, Mirfazaelian H, Jalili M. How much change in pain score does really matter to patients? Am J Emerg Med. 2020 Aug;38(8):1641-1646. doi: 10.1016/j.ajem.2019.158489. Epub 2019 Nov 4.
- BackgroundBain, G., Eygendaal, D., and van Riet, R. (2020). Surgical Techniques for Trauma and Sports Related Injuries of the Elbow
- Background: PubMed 3722222Broberg MA, Morrey BF. Results of delayed excision of the radial head after fracture. J Bone Joint Surg Am. 1986 Jun;68(5):669-74.
- Background: PubMed 27125506Churchill RW, Munoz J, Ahmad CS. Osteochondritis dissecans of the elbow. Curr Rev Musculoskelet Med. 2016 Jun;9(2):232-9. doi: 10.1007/s12178-016-9342-y.
- Background: PubMed 16814787Court-Brown CM, Caesar B. Epidemiology of adult fractures: A review. Injury. 2006 Aug;37(8):691-7. doi: 10.1016/j.injury.2006.04.130. Epub 2006 Jun 30.
- Background: PubMed 24656392Cusick MC, Bonnaig NS, Azar FM, Mauck BM, Smith RA, Throckmorton TW. Accuracy and reliability of the Mayo Elbow Performance Score. J Hand Surg Am. 2014 Jun;39(6):1146-50. doi: 10.1016/j.jhsa.2014.01.041. Epub 2014 Mar 20.
- Background: PubMed 28833869Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018 Jan;27(1):7-22. doi: 10.1002/hec.3564. Epub 2017 Aug 22.
- Background: PubMed 23365021Duckworth AD, McQueen MM, Ring D. Fractures of the radial head. Bone Joint J. 2013 Feb;95-B(2):151-9. doi: 10.1302/0301-620X.95B2.29877.
- Background: PubMed 23827844Fowler JR, Goitz RJ. Radial head fractures: indications and outcomes for radial head arthroplasty. Orthop Clin North Am. 2013 Jul;44(3):425-31, x. doi: 10.1016/j.ocl.2013.03.013. Epub 2013 Apr 17.
- Background: PubMed 23728684Gao Y, Zhang W, Duan X, Yang J, Al-Qwbani M, Lv J, Xiang Z. Surgical interventions for treating radial head fractures in adults. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008987. doi: 10.1002/14651858.CD008987.pub2.
- Background: PubMed 21724620Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011 Oct;107(4):619-26. doi: 10.1093/bja/aer195. Epub 2011 Jun 30.
- Individual participant dataSharing planned: No
Related trials for Radial Head Fractures
Active, not recruiting
RHEVOLUTION Clinical Trial: Use of Two Radial Head Arthroplasty Designs for the Treatment of Elbow Instability
Elbow Arthropathy, Elbow Dislocation
Recruiting
The Utilization of Ultrasound to Diagnose Pediatric Elbow Fractures
Elbow Pain, Supracondylar Humerus Fracture
Recruiting
Opioid-Free Pain Treatment in Trauma Patients
Femoral Neck Fractures, Intertrochanteric Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
DePuy Synthes Products, Inc. Clinical Trial study director
DePuy Synthes Products, Inc.
4 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Radial Head Fractures, run by DePuy Synthes Products, Inc. at 4 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 16 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Device survivorship Over the First 6 Months Post-implantation (time frame: 6 months post-implantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05415592, which also lists 31 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2023.